Search results
Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income Projections Amid Strategic ...
GuruFocus.com via Yahoo Finance· 7 hours agoFulcrum's ability to secure FDA Fast Track and Orphan Drug Designations for its lead compounds...
Earnings call: Esperion reveals robust Q1 growth, FDA approval boosts By Investing.com
Investing.com· 6 days agoEsperion Therapeutics Inc. (NASDAQ:ESPR) has reported a significant surge in its first-quarter...
Earnings call: Viridian Therapeutics reports robust progress in Q1 2024 By Investing.com
Investing.com· 4 days agoViridian Therapeutics (VRDN), a biotechnology company specializing in the treatment of thyroid eye...
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoZevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2024 Earnings Call Transcript May 8, 2024 Zevra ...
FDA To Hold Advisory Committee Meeting On MDMA Therapy For PTSD, Welcomes Public Comment
Forbes· 3 days agoThe U.S. Food and Drug Administration (FDA) recently announced an upcoming committee meeting...
Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income
Guru Focus· 6 hours agoOn May 13, 2024, Fulcrum Therapeutics Inc (FULC, Financial) disclosed its financial outcomes for the first quarter of 2024 through an 8-K filing. The Cambridge-based clinical-stage ...
Earnings call: Aquestive Therapeutics highlights progress and outlook for 2024
Investing.com· 5 days agoThe company also raised over $75 million in new capital and saw an 8% increase in total revenues,...
Earnings call: Virios Therapeutics reports on Q1 2024 progress By Investing.com
Investing.com· 21 hours agoVirios Therapeutics (NASDAQ: VIRI) discussed their first quarter financial results and provided an...
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the...
Morningstar· 9 hours agoFulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with ...
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoLENZ Therapeutics, Inc. (NASDAQ:LENZ) Q1 2024 Earnings Call Transcript May 11, 2024 LENZ ...